Literature DB >> 15185013

Dendritic cells reduce number and function of CD4+CD25+ cells in cytokine-induced killer cells derived from patients with pancreatic carcinoma.

Jan Schmidt1, Sven Eisold, Markus W Büchler, Angela Märten.   

Abstract

AIM AND
BACKGROUND: CD4+CD25+ cells are described as professional regulatory/suppressor T cells that are crucial for the prevention of spontaneous autoimmune diseases. They play an important role in maintaining a balanced peripheral immune system. On the other hand, it has been suggested that regulatory T cells (Treg) suppress antitumor immune responses after tumor-specific vaccinations. Therefore, we determined the percentage of regulatory T cells in cytokine-induced killer (CIK) cells, an effector cell population with high impact for adoptive immunotherapeutic strategies.
RESULTS: CIK cells showed strong induction of CD4+CD25+ cells with high secretion of interleukin 10 (IL-10) after unspecific stimulation of the TCR complex and stimulation with interleukin 2. Depletion of CD25+ cells led to an increase in cytotoxic activity and a reduction of IL-10 release. A more pronounced reversal of suppression could be induced by coculture of CIK cells with dendritic cells (DCs). After coculture of CIK cells with DCs, the number of CD4+CD25+ cells as well as the IL-10 concentration in the supernatant decreased, and the cytotoxic activity against pancreatic carcinoma cells increased. This was shown for cells from healthy donors as well as for cells from patients with pancreatic carcinoma.
CONCLUSION: Our established effector cells possess some regulatory features induced by unspecific TCR-activation that could be prevented by coculture with DCs. CIK cells have desirable properties for immunotherapeutical approaches, especially after coculture with DCs, which could be used additionally for induction of a specific immune response.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15185013     DOI: 10.1007/s00262-004-0554-4

Source DB:  PubMed          Journal:  Cancer Immunol Immunother        ISSN: 0340-7004            Impact factor:   6.968


  17 in total

1.  Dendritic cells pulsed with total tumor RNA for activation NK-like T cells against glioblastoma multiforme.

Authors:  Prachya Vichchatorn; Adisak Wongkajornsilp; Sawang Petvises; Sumalee Tangpradabkul; Samart Pakakasama; Suradej Hongeng
Journal:  J Neurooncol       Date:  2005-11       Impact factor: 4.130

2.  CD83(+) dendritic cells and Foxp3(+) regulatory T cells in primary lesions and regional lymph nodes are inversely correlated with prognosis of gastric cancer.

Authors:  Seigo Kashimura; Zenichiro Saze; Masanori Terashima; Nobutoshi Soeta; Satoshi Ohtani; Fumihiko Osuka; Michihiko Kogure; Mitsukazu Gotoh
Journal:  Gastric Cancer       Date:  2011-11-15       Impact factor: 7.370

3.  Cisplatin pretreatment enhances anti-tumor activity of cytokine-induced killer cells.

Authors:  Xiang Huang; Yi-Tian Chen; Hai-Zhu Song; Gui-Chun Huang; Long-Bang Chen
Journal:  World J Gastroenterol       Date:  2011-07-07       Impact factor: 5.742

4.  Bioactivity of umbilical cord blood dendritic cells and anti-leukemia effect.

Authors:  Xu-Cang Wei; Di-Di Yang; Xiu-Rui Han; Yu-An Zhao; Yan-Chun Li; Li-Jie Zhang; Jiu-Ju Wang
Journal:  Int J Clin Exp Med       Date:  2015-10-15

5.  Immune activation by combination human lymphokine-activated killer and dendritic cell therapy.

Authors:  E J West; K J Scott; V A Jennings; A A Melcher
Journal:  Br J Cancer       Date:  2011-08-16       Impact factor: 7.640

6.  Pulsing with blast cell lysate or blast-derived total RNA reverses the dendritic cell-mediated cytotoxic activity of cytokine-induced killer cells against allogeneic acute myelogenous leukemia cells.

Authors:  Björn Schöttker; Ingo G H Schmidt-Wolf
Journal:  Ger Med Sci       Date:  2011-08-04

7.  Targeting regulatory T cells in cytokine-induced killer cell cultures (Review).

Authors:  Qianshan Tao; Huiping Wang; Zhimin Zhai
Journal:  Biomed Rep       Date:  2014-02-07

8.  Dendritic cells decreased the concomitant expanded Tregs and Tregs related IL-35 in cytokine-induced killer cells and increased their cytotoxicity against leukemia cells.

Authors:  Ying Pan; Qianshan Tao; Huiping Wang; Shudao Xiong; Rui Zhang; Tianping Chen; Lili Tao; Zhimin Zhai
Journal:  PLoS One       Date:  2014-04-04       Impact factor: 3.240

9.  Effect of anti-asthma Chinese medicine Chuankezhi on the anti-tumor activity of cytokine-induced killer cells.

Authors:  Jing-Jing Zhao; Ke Pan; Qi-Jing Wang; Zheng-Di Xu; De-Sheng Weng; Jian-Jun Li; Yong-Qiang Li; Jian-Chuan Xia
Journal:  Chin J Cancer       Date:  2013-03-08

10.  Sunitinib indirectly enhanced anti-tumor cytotoxicity of cytokine-induced killer cells and CD3⁺CD56⁺ subset through the co-culturing dendritic cells.

Authors:  Adisak Wongkajornsilp; Valla Wamanuttajinda; Kanda Kasetsinsombat; Sunisa Duangsa-ard; Khanit Sa-ngiamsuntorn; Suradej Hongeng; Kittipong Maneechotesuwan
Journal:  PLoS One       Date:  2013-11-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.